WCPO: UC scientist finds new solution to fight superbug infections
Professor Hassett takes on some of the nastiest infections resistant to antibiotics
Journalist Paulo Suro speaks with Daniel Hassett, PhD, professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology, about his patented treatment AB569 and its possible use to treat cystic fibrosis, chronic obstructive pulmonary disease and other infections. AB569 tackles some of the nastiest superbugs on the planet and currently being tested in human trials to ensure its safety for future patients.
Related Stories
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.
Everyday guide to AI prompt engineering
August 5, 2026
Prompt engineering can be the difference between strong and poor AI outputs. Success comes from explaining your end goal, breaking down large requests and carefully checking for errors.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.